BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
8 results:

  • 1. Genome-wide analysis of colorectal cancer based on gene-based somatic copy number alterations during neoplastic progression within the same tumor.
    Yamada S; Osakabe M; Uesugi N; Yanagawa N; Matsumoto T; Suzuki H; Sugai T
    Cancer Med; 2023 Feb; 12(4):4446-4454. PubMed ID: 35920319
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
    Sveen A; Johannessen B; Tengs T; Danielsen SA; Eilertsen IA; Lind GE; Berg KCG; Leithe E; Meza-Zepeda LA; Domingo E; Myklebost O; Kerr D; Tomlinson I; Nesbakken A; Skotheim RI; Lothe RA
    Genome Med; 2017 May; 9(1):46. PubMed ID: 28539123
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/torc1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effective targeting of colorectal cancer cells using torc1/2 kinase inhibitors in vitro and in vivo.
    Zhang J; Jiang W; Liu W; Wu JJ; Song L; Cheng JX; Yao M; Yang LP; Yao DF
    Future Oncol; 2016 Feb; 12(4):515-24. PubMed ID: 26776341
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dysregulated crtc1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.
    Schumacher Y; Aparicio T; Ourabah S; Baraille F; Martin A; Wind P; Dentin R; Postic C; Guilmeau S
    Oncogene; 2016 May; 35(20):2602-14. PubMed ID: 26300003
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.
    Faber AC; Coffee EM; Costa C; Dastur A; Ebi H; Hata AN; Yeo AT; Edelman EJ; Song Y; Tam AT; Boisvert JL; Milano RJ; Roper J; Kodack DP; Jain RK; Corcoran RB; Rivera MN; Ramaswamy S; Hung KE; Benes CH; Engelman JA
    Cancer Discov; 2014 Jan; 4(1):42-52. PubMed ID: 24163374
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
    Cazorla A; Viennet G; Uro-Coste E; Valmary-Degano S
    J Craniomaxillofac Surg; 2014 Apr; 42(3):262-4. PubMed ID: 23830771
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer.
    García-Mauriño S; Alcaide A; Domínguez C
    Curr Pharm Des; 2012; 18(26):3853-73. PubMed ID: 22632751
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.